Voyager Therapeutics logo

Voyager Therapeutics Share Price Today

(NASDAQ: VYGR)

Voyager Therapeutics share price is $5.53 & ₹483.16 as on 5 Feb 2025, 2.30 'hrs' IST

$5.53

▲

0.2

(3.75%)

Market is closed - opens 8 PM, 05 Feb 2025

View live Voyager Therapeutics share price in Dollar and Rupees. Guide to invest in Voyager Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Voyager Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Voyager Therapeutics share price movements

  • Today's Low: $5.28
    Today's High: $5.54

    Day's Volatility :4.69%

  • 52 Weeks Low: $4.99
    52 Weeks High: $10.66

    52 Weeks Volatility :53.19%

Voyager Therapeutics (VYGR) Returns

PeriodVoyager Therapeutics, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-24.04%
-0.5%
0.0%
6 Months
-21.45%
0.1%
0.0%
1 Year
-24.97%
3.2%
0.0%
3 Years
66.57%
11.1%
-11.7%

Voyager Therapeutics (VYGR) Key Statistics

in dollars & INR

Previous Close
$5.33
Open
$5.33
Today's High
$5.54
Today's Low
$5.28
Market Capitalization
$291.2M
Today's Volume
$205.9K
52 Week High
$10.66
52 Week Low
$4.99
Revenue TTM
$163.8M
EBITDA
$14.1M
Earnings Per Share (EPS)
$0.66
PE Ratio
8.08
Profit Margin
15.8%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
10.22%

How to invest in Voyager Therapeutics Stock (VYGR) from India?

It is very easy for Indian residents to invest directly in Voyager Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Voyager Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Voyager Therapeutics or VYGR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Voyager Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Voyager Therapeutics shares which would translate to 0.158 fractional shares of Voyager Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Voyager Therapeutics, in just a few clicks!

Returns in Voyager Therapeutics (VYGR) for Indian investors in Rupees

The Voyager Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Voyager Therapeutics investment value today

Current value as on today

₹80,269

Returns

₹19,731

(-19.73%)

Returns from Voyager Therapeutics Stock

₹24,966 (-24.97%)

Dollar Returns

₹5,235 (+5.23%)

Indian investors sentiment towards Voyager Therapeutics (VYGR)

-30%

Period: Jan 5, 2025 to Feb 4, 2025. Change in 30 Days versus previous period

Search interest for Voyager Therapeutics Stock from India on INDmoney has decreased by -30% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Voyager Therapeutics

  • BlackRock Inc

    9.94%

  • Armistice Capital, LLC

    9.52%

  • EcoR1 Capital, LLC

    7.17%

  • Vanguard Group Inc

    5.83%

  • Farallon Capital Management, L.L.C.

    4.20%

  • Dimensional Fund Advisors, Inc.

    2.02%

Analyst Recommendation on Voyager Therapeutics

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 16 Wall street analysts offering stock ratings for Voyager Therapeutics(by analysts ranked 0 to 5 stars)

Based on 16 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
14
14
11
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Voyager Therapeutics Stock (VYGR)

What analysts predicted

Upside of 209.22%

Target:

$17.10

Current:

$5.53

Insights on Voyager Therapeutics Stock (Ticker Symbol: VYGR)

  • Price Movement

    In the last 6 months, VYGR stock has moved down by -30.6%

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 29.57M → 24.62M (in $), with an average decrease of 16.7% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -11.33M → -9.04M (in $), with an average increase of 11.9% per quarter

  • VYGR vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 58.8% return, outperforming this stock by 83.7%

  • VYGR vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 86.4% return, outperforming this stock by 15.7%

  • Price to Sales

    ForVYGR every $1 of sales, investors are willing to pay $1.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.4 for every $1 of sales.

VYGR Voyager Therapeutics Financials in INR & Dollars

FY18Y/Y Change
Revenue
$7.6M
↓ 24.82%
Net Income
$-88.3M
↑ 24.88%
Net Profit Margin
-1.2K%
↓ 461.23%
FY19Y/Y Change
Revenue
$104.4M
↑ 1270.14%
Net Income
$-40.8M
↓ 53.75%
Net Profit Margin
-39.11%
↑ 1119.68%
FY20Y/Y Change
Revenue
$171.1M
↑ 63.93%
Net Income
$36.7M
↓ 189.98%
Net Profit Margin
21.47%
↑ 60.58%
FY21Y/Y Change
Revenue
$37.4M
↓ 78.14%
Net Income
$-66.0M
↓ 279.72%
Net Profit Margin
-176.49%
↓ 197.96%
FY22Y/Y Change
Revenue
$40.9M
↑ 9.33%
Net Income
$-46.4M
↓ 29.72%
Net Profit Margin
-113.45%
↑ 63.04%
FY23Y/Y Change
Revenue
$250.0M
↑ 511.16%
Net Income
$132.3M
↓ 385.14%
Net Profit Margin
52.93%
↑ 166.38%
Q2 FY23Q/Q Change
Revenue
$4.9M
↓ 96.77%
Net Income
$-22.2M
↓ 117.9%
Net Profit Margin
-457.61%
↓ 540.04%
Q3 FY23Q/Q Change
Revenue
$4.6M
↓ 4.92%
Net Income
$-25.9M
↑ 16.63%
Net Profit Margin
-561.36%
↓ 103.75%
Q4 FY23Q/Q Change
Revenue
$90.1M
↑ 1851.91%
Net Income
$56.4M
↓ 317.73%
Net Profit Margin
62.62%
↑ 623.98%
Q1 FY24Q/Q Change
Revenue
$19.5M
↓ 78.33%
Net Income
$-11.3M
↓ 120.09%
Net Profit Margin
-58.05%
↓ 120.67%
Q2 FY24Q/Q Change
Revenue
$29.6M
↑ 51.56%
Net Income
$-10.1M
↓ 10.49%
Net Profit Margin
-34.29%
↑ 23.76%
Q3 FY24Q/Q Change
Revenue
$24.6M
↓ 16.73%
Net Income
$-9.0M
↓ 10.82%
Net Profit Margin
-36.72%
↓ 2.43%
FY18Y/Y Change
Profit
$7.6M
↓ 24.82%
FY19Y/Y Change
Profit
$104.4M
↑ 1270.14%
FY20Y/Y Change
Profit
$62.4M
↓ 40.25%
FY21Y/Y Change
Profit
$37.4M
↓ 40.02%
FY22Y/Y Change
Profit
$40.9M
↑ 9.33%
FY23Y/Y Change
Profit
$245.6M
↑ 500.31%
Q2 FY23Q/Q Change
Profit
$3.8M
↓ 97.48%
Q3 FY23Q/Q Change
Profit
$3.7M
↓ 2.6%
Q4 FY23Q/Q Change
Profit
$88.7M
↑ 2318.26%
Q1 FY24Q/Q Change
Profit
$18.3M
↓ 79.35%
Q2 FY24Q/Q Change
Profit
$-4.9M
↓ 126.6%
Q3 FY24Q/Q Change
Profit
$24.6M
↓ 605.31%
FY18Y/Y Change
Operating Cash Flow
$-15.9M
↓ 74.1%
Investing Cash Flow
$26.5M
↓ 819.02%
Financing Cash Flow
$4.7M
↓ 92.07%
FY19Y/Y Change
Operating Cash Flow
$48.7M
↓ 406.33%
Investing Cash Flow
$-90.5M
↓ 441.85%
Financing Cash Flow
$81.0M
↑ 1605.5%
FY20Y/Y Change
Operating Cash Flow
$-96.7M
↓ 298.73%
Investing Cash Flow
$113.0M
↓ 224.89%
Financing Cash Flow
$3.2M
↓ 96.09%
FY21Y/Y Change
Operating Cash Flow
$-53.5M
↓ 44.66%
Investing Cash Flow
$65.9M
↓ 41.67%
Financing Cash Flow
$612.0K
↓ 80.65%
FY22Y/Y Change
Operating Cash Flow
$-12.5M
↓ 76.63%
Investing Cash Flow
$-7.3M
↓ 111.14%
Financing Cash Flow
$1.1M
↑ 81.37%
Q2 FY23Q/Q Change
Operating Cash Flow
$-835.0K
↓ 100.68%
Investing Cash Flow
$-24.7M
↓ 270.2%
Financing Cash Flow
$1.5M
↓ 95.06%

Voyager Therapeutics Technicals Summary

Sell

Neutral

Buy

Voyager Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Voyager Therapeutics (VYGR) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Voyager Therapeutics, Inc. logo
Voyager Therapeutics, Inc.
-8.14%
-21.45%
-24.97%
66.57%
-57.33%
Biontech Se logo
Biontech Se
-2.55%
47.81%
22.02%
-32.21%
279.34%
Regeneron Pharmaceuticals, Inc. logo
Regeneron Pharmaceuticals, Inc.
-2.68%
-34.72%
-25.67%
12.0%
82.54%
Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated
19.82%
3.52%
15.9%
98.26%
100.9%
Alnylam Pharmaceuticals, Inc. logo
Alnylam Pharmaceuticals, Inc.
16.23%
4.16%
57.39%
82.31%
115.97%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Voyager Therapeutics, Inc. logo
Voyager Therapeutics, Inc.
8.08
8.08
0.0
-0.91
0.1
0.02
NA
6.06
Biontech Se logo
Biontech Se
160.8
NA
0.04
-3.37
-0.02
-0.01
NA
79.73
Regeneron Pharmaceuticals, Inc. logo
Regeneron Pharmaceuticals, Inc.
16.49
16.49
1.08
44.92
0.17
0.07
NA
272.04
Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated
32.84
NA
1.21
0.48
-0.03
0.12
NA
60.65
Alnylam Pharmaceuticals, Inc. logo
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.18
-15.01
-0.03
NA
0.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Voyager Therapeutics, Inc. logo
Voyager Therapeutics, Inc.
Buy
$291.2M
-57.33%
8.08
15.8%
Biontech Se logo
Biontech Se
Buy
$28.7B
279.34%
160.8
-15.36%
Regeneron Pharmaceuticals, Inc. logo
Regeneron Pharmaceuticals, Inc.
Buy
$73.3B
82.54%
16.49
33.61%
Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated
Buy
$121.1B
100.9%
32.84
-4.51%
Alnylam Pharmaceuticals, Inc. logo
Alnylam Pharmaceuticals, Inc.
Buy
$35.4B
115.97%
NA
-15.86%

About Voyager Therapeutics

Voyager Therapeutics, Inc., a biotechnology company, focuses on the treatment of gene therapy and neurology diseases. The company's lead clinical candidate is VY-TAU01, an anti-tau antibody program for the treatment of alzheimer's disease. Its product pipeline includes superoxide dismutase 1 silencing gene therapy, which is in preclinical trial for the treatment of amyotrophic lateral sclerosis; tau silencing gene therapy, which is in preclinical trial for the treatment of alzheimer's disease; and vectorized anti-amyloid antibody, a gene therapy targeting anti-amyloid for the treatment of alzheimer's disease and is in preclinical trial. In addition, the company develops VY-FXN01, which is in preclinical trial to treat friedreich's ataxia; and GBA1 gene replacement to treat parkinson's disease and is in preclinical trial. Further, it provides research program for the treatment of Huntington's disease. The company has collaboration and license agreements with Alexion; AstraZeneca Rare Disease; Novartis Pharma AG; Neurocrine Biosciences, Inc; and Sangamo Therapeutics, Inc. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.
Organization
Voyager Therapeutics
Employees
162
CEO
Dr. Alfred W. Sandrock Jr., M.D., Ph.D.
Industry
Health Technology

Management People of Voyager Therapeutics

NameTitle
Dr. Alfred W. Sandrock Jr., M.D., Ph.D.
President, CEO & Director
Ms. Robin Swartz
Chief Business Officer & COO
Ms. Jacquelyn Fahey Sandell Esq., J.D.
Chief Legal Officer
Dr. Krystof Bankiewicz M.D., Ph.D.
Founder
Dr. Guangping Gao Ph.D.
Founder & Member of Scientific Advisory Board
Dr. Mark A. Kay M.D., Ph.D.
Founder
Dr. Phillip D. Zamore Ph.D.
Founder & Member of Scientific Advisory Board
Dr. Nathan D. Jorgensen M.B.A., Ph.D.
Chief Financial Officer
Mr. Todd Carter Ph.D.
Chief Scientific Officer
Ms. Michelle Quinn Smith
Chief Human Resources Officer

Important FAQs about investing in VYGR Stock from India :

What is Voyager Therapeutics share price today?

Voyager Therapeutics share price today stands at $5.53, Open: $5.33 ; Previous Close: $5.33 ; High: $5.54 ; Low: $5.28 ; 52 Week High: $10.66 ; 52 Week Low: $4.99.

The stock opens at $5.33, after a previous close of $5.33. The stock reached a daily high of $5.54 and a low of $5.28, with a 52-week high of $10.66 and a 52-week low of $4.99.

Can Indians buy Voyager Therapeutics shares?

Yes, Indians can invest in the Voyager Therapeutics (VYGR) from India.

With INDmoney, you can buy Voyager Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Voyager Therapeutics at zero transaction cost.

How can I buy Voyager Therapeutics shares from India?

It is very easy to buy Voyager Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Voyager Therapeutics (VYGR) be purchased?

Yes, you can buy fractional shares of Voyager Therapeutics with INDmoney app.

What are the documents required to start investing in Voyager Therapeutics stocks?

To start investing in Voyager Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Voyager Therapeutics Stock (VYGR)?

Today’s highest price of Voyager Therapeutics (VYGR) is $5.54.

Today’s lowest price of Voyager Therapeutics (VYGR) is $5.28.

What is today's market capitalisation of Voyager Therapeutics?

Today's market capitalisation of Voyager Therapeutics VYGR is 291.2M

What is the 52 Week High and Low Range of Voyager Therapeutics Stock (VYGR)?

  • 52 Week High

    $10.66

  • 52 Week Low

    $4.99

What are the historical returns of Voyager Therapeutics (VYGR)?

  • 1 Month Returns

    -8.14%

  • 3 Months Returns

    -21.45%

  • 1 Year Returns

    -24.97%

  • 5 Years Returns

    -57.33%

Who is the Chief Executive Officer (CEO) of Voyager Therapeutics ?

Dr. Alfred W. Sandrock Jr., M.D., Ph.D. is the current Chief Executive Officer (CEO) of Voyager Therapeutics.